Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized Clinical Trial

Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized Clinical Trial

ABSTRACT: Background: Hypertension and dyslipidemia significantly contribute to cardiovascular disease development. Their coexistence poses challenges in managing multiple medications, influencing treatment adherence. Objective: This study aimed to assess the efficacy and safety of a combined treat...

Full description

Bibliographic Details
Main Authors: Sungjoon Park, MD, Doyeon Hwang, MD, Jeehoon Kang, MD, Jung-Kyu Han, MD, Han-Mo Yang, MD, Kyung Woo Park, MD, Hyun-Jae Kang, MD, Bon-Kwon Koo, MD, Jin-Man Cho, MD, Byung-Ryul Cho, MD, Sung Gyun Ahn, MD, Seok-Min Kang, MD, Jung-Hoon Sung, MD, Ung Kim, MD, Namho Lee, MD, Hyo-Soo Kim, MD
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Current Therapeutic Research
Subjects:
atorvastatin
dyslipidemia
hypertension
LDL-C
rosuvastatin
telmisartan
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X24000055

Internet

http://www.sciencedirect.com/science/article/pii/S0011393X24000055

Similar Items